Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online February 25, 2009.
Article Versions
- Latest version (January 23, 2009 - 05:58).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2009 The American Association for Clinical Chemistry
Author Information
- John H. Contois1,a,2,
- Joseph P. McConnell2,
- Amar A. Sethi3,
- Gyorgy Csako3,
- Sridevi Devaraj4,
- Daniel M. Hoefner5 and
- G. Russell Warnick6
- 1Maine Standards Company, Windham, ME;2 Mayo Clinic, Rochester, MN;3 National Institutes of Health, Bethesda, MD;4 UC Davis Medical Center, Sacramento, CA;5 Marshfield Clinic, Marshfield, WI;6 Berkeley HeartLab Inc, Alameda, CA.
- ↵aAddress correspondence to this author at: Maine Standards Company LLC, 765 Roosevelt Trail, Windham, ME 04062. Fax 207-892-2266; e-mail jcontois{at}mainestandards.com.
Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
Jump to section
- Article
- Abstract
- apo b-containing lipoproteins and cvd risk
- apo b structure and function
- apo b genetics
- disorders of apo b
- prospective studies of apo b in primary and secondary prevention
- ldl-lowering treatment and residual cvd risk
- management of ldl-related risk
- non-hdl cholesterol
- measurement issues
- Acknowledgments
- Footnotes
- References
- Figures & Data
- Info & Metrics